<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
<journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
<journal-id journal-id-type="pmc">F1000Research</journal-id>
<journal-title-group>
<journal-title>F1000Research</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-1402</issn>
<publisher>
<publisher-name>F1000 Research Limited</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31984132</article-id>
<article-id pub-id-type="pmc">6966773</article-id>
<article-id pub-id-type="doi">10.12688/f1000research.16315.1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The genetics of intellectual disability: advancing technology and gene editing</article-title>
<fn-group content-type="pub-status">
<fn>
<p>[version 1; peer review: 2 approved]</p>
</fn>
</fn-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ilyas</surname>
<given-names>Muhammad</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0675-3498</contrib-id>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Mir</surname>
<given-names>Asif</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<xref ref-type="corresp" rid="c1">a</xref>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Efthymiou</surname>
<given-names>Stephanie</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4900-9877</contrib-id>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Houlden</surname>
<given-names>Henry</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding Acquisition</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2866-7777</contrib-id>
<xref ref-type="corresp" rid="c2">b</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<aff id="a1">
<label>1</label>Department of Biological Sciences, International Islamic University Islamabad, Islamabad, 44000, Pakistan</aff>
<aff id="a2">
<label>2</label>Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK</aff>
</contrib-group>
<author-notes>
<corresp id="c1">
<label>a</label>
<email xlink:href="mailto:asif.mir@iiu.edu.pk">asif.mir@iiu.edu.pk</email>
</corresp>
<corresp id="c2">
<label>b</label>
<email xlink:href="mailto:h.houlden@ucl.ac.uk">h.houlden@ucl.ac.uk</email>
</corresp>
<fn fn-type="COI-statement">
<p>No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>9</volume>
<elocation-id>F1000 Faculty Rev-22</elocation-id>
<history>
<date date-type="accepted">
<day>10</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2020 Ilyas M et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="f1000research-9-17823.pdf"></self-uri>
<abstract>
<p>Intellectual disability (ID) is a neurodevelopmental condition affecting 1–3% of the world’s population. Genetic factors play a key role causing the congenital limitations in intellectual functioning and adaptive behavior. The heterogeneity of ID makes it more challenging for genetic and clinical diagnosis, but the advent of large-scale genome sequencing projects in a trio approach has proven very effective. However, many variants are still difficult to interpret. A combined approach of next-generation sequencing and functional, electrophysiological, and bioinformatics analysis has identified new ways to understand the causes of ID and help to interpret novel ID-causing genes. This approach offers new targets for ID therapy and increases the efficiency of ID diagnosis. The most recent functional advancements and new gene editing techniques involving the use of CRISPR–Cas9 allow for targeted editing of DNA in
<italic>in vitro</italic> and more effective mammalian and human tissue-derived disease models. The expansion of genomic analysis of ID patients in diverse and ancient populations can reveal rare novel disease-causing genes.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Intellectual Disability</kwd>
<kwd>Neurological Disorders</kwd>
<kwd>Gene Editing</kwd>
<kwd>Mental Retrdation</kwd>
<kwd>NGS</kwd>
<kwd>WES</kwd>
<kwd>CRISPR/Cas9.</kwd>
</kwd-group>
<funding-group>
<award-group id="fund-1">
<funding-source>Sparks GOSH Charity</funding-source>
</award-group>
<award-group id="fund-2" xlink:href="http://dx.doi.org/10.13039/100013790">
<funding-source>Brain Research UK</funding-source>
</award-group>
<award-group id="fund-3" xlink:href="http://dx.doi.org/10.13039/501100010221">
<funding-source>Higher Education Commision, Pakistan</funding-source>
<award-id>Project7028_NRPU</award-id>
</award-group>
<award-group id="fund-4">
<funding-source>The National Institute for Health Research University College London Hospitals Biomedical Research Centre</funding-source>
</award-group>
<award-group id="fund-5">
<funding-source>Rosetree Trust</funding-source>
</award-group>
<award-group id="fund-6">
<funding-source>Ataxia UK</funding-source>
</award-group>
<award-group id="fund-7" xlink:href="http://dx.doi.org/10.13039/100011724">
<funding-source>Muscular Dystrophy UK</funding-source>
</award-group>
<award-group id="fund-8" xlink:href="http://dx.doi.org/10.13039/100013128">
<funding-source>Multiple System Atrophy Trust</funding-source>
</award-group>
<award-group id="fund-9">
<funding-source>The Medical Research Council</funding-source>
<award-id>MR/S01165X/1</award-id>
<award-id>MR/S005021/1</award-id>
<award-id>G0601943</award-id>
</award-group>
<funding-statement>The authors’ work is funded by the MRC (MR/S01165X/1, MR/S005021/1, G0601943), The National Institute for Health Research University College London Hospitals Biomedical Research Centre, Rosetree Trust, Ataxia UK, MSA Trust, Brain Research UK, Sparks GOSH Charity, Muscular Dystrophy UK (MDUK), Muscular Dystrophy Association (MDA USA), and Higher Education Commission of Pakistan (Project 7028_NRPU). </funding-statement>
<funding-statement>
<italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
</funding-statement>
</funding-group>
</article-meta>
<notes>
<sec sec-type="editor-note">
<title>Editorial Note on the Review Process</title>
<p>
<ext-link ext-link-type="uri" xlink:href="http://f1000research.com/browse/f1000-faculty-reviews">F1000 Faculty Reviews</ext-link> are commissioned from members of the prestigious
<ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/thefaculty">F1000 Faculty</ext-link> and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).</p>
<p>The referees who approved this article are: </p>
<list list-content="reviewer-list" list-type="simple">
<list-item>
<p>
<named-content content-type="reviewer-name">Jennifer Winter</named-content>, Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Hao Hu</named-content>, Guangzhou Women and Children’s Medical Center, Guangzhou, China; Max-Planck Institute for Molecular Genetics, Berlin, Germany
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
</list>
</sec>
</notes>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Intellectual disability (ID) occurs in the developmental period before the age of 18 years. ID is a heterogeneous group of disorders characterized by significantly impaired intellectual functioning and deficits in adaptive behaviors
<sup><xref ref-type="bibr" rid="ref-1">1</xref></sup>. It affects 1–3% of the world population, is the most common developmental disorder, and represents an important socio-economic problem in healthcare. However, owing to the heterogeneity of ID, its frequency ratio changes worldwide
<sup><xref ref-type="bibr" rid="ref-2">2</xref></sup>. Diagnosis of ID is also performed with the identification of clinical phenotype symptoms such as delayed speech, hypotonia, and seizures
<sup><xref ref-type="bibr" rid="ref-3">3</xref></sup>. In the past decade, the genetic background of ID was believed to be mostly autosomal dominant (
<italic>de novo</italic> mutations) in the outbred countries such as the USA and those in Western Europe, while in the middle-east countries where inbreeding is common, autosomal recessive ID has some preponderance
<sup><xref ref-type="bibr" rid="ref-4">4</xref>,
<xref ref-type="bibr" rid="ref-5">5</xref></sup>.</p>
<p>Next-generation sequencing (NGS) provided tremendous power to sequence personal genomes and detect a large number of genetic variants. The discovery of disease-causing variants by whole exome or genome sequencing in patients has dramatically changed our perspective on precision medicine
<sup><xref ref-type="bibr" rid="ref-6">6</xref></sup>. Through NGS methods, now it is possible to find pathogenic mutations, including novel mutations, associated with ID
<sup><xref ref-type="bibr" rid="ref-7">7</xref></sup>. A combined NGS and bioinformatics approach is used to identify novel ID genes and screen candidate ID genes as well. NGS has efficiently expedited ID research and provided new strategies at the clinical level in the last few years, as shown in
<xref ref-type="fig" rid="f1">Figure 1</xref>. Genomics England’s PanelApp database (
<ext-link ext-link-type="uri" xlink:href="https://panelapp.genomicsengland.co.uk/panels/285/">https://panelapp.genomicsengland.co.uk/panels/285/</ext-link>) shows that around 1,396 genes cause ID (see Table 1,
<italic>Extended data</italic>).</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="anchor">
<label>Figure 1. </label>
<caption>
<title>The number of articles on intellectual disability published in the last seven years identified using the PubMed search terms “ID”, “mental retardation”, “next-generation sequencing”, and “exome sequencing”.</title>
</caption>
<graphic xlink:href="f1000research-9-17823-g0000"></graphic>
</fig>
</sec>
<sec>
<title>Etiological classification of intellectual disability</title>
<p>Multiple factors are involved in causing ID. Genetic factors include genetic variations such as aneuploidies, copy number variations (CNVs), and tandem repeats in specific genes
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup>. DNA is liable to mutation, mediating genetic plasticity. The expansion of tandem repeats can cause a range of disorders associated with ID such as X-linked ID (XLID)
<sup><xref ref-type="bibr" rid="ref-9">9</xref></sup>, various ataxias, motor neuron disease, and epilepsy. Emerging data suggest that tandem repeat polymorphisms (TRPs) can contribute to the missing heritability of polygenic disorders
<sup><xref ref-type="bibr" rid="ref-10">10</xref>–
<xref ref-type="bibr" rid="ref-13">13</xref></sup>. Furthermore, various metabolic factors, repeat expansions of nucleotides, and mitochondrial DNA variants can also contribute to ID
<sup><xref ref-type="bibr" rid="ref-7">7</xref></sup>. Environmental factors such as hazardous chemical exposures, infections during pregnancy, and UV radiation are also reported to cause ID. In addition to these, lack of nutrition, cultural deprivation, childhood diseases such as measles, meningitis, and severe head injury can cause malfunction of the nervous system, leading to ID
<sup><xref ref-type="bibr" rid="ref-14">14</xref></sup>. Even though the etiological factors of ID are very broad, as shown in
<xref ref-type="fig" rid="f2">Figure 2</xref>, in 50% of individuals the cause of ID is still unknown, but the most prominent causes are genetic
<sup><xref ref-type="bibr" rid="ref-15">15</xref></sup>.</p>
<fig fig-type="figure" id="f2" orientation="portrait" position="anchor">
<label>Figure 2. </label>
<caption>
<title>Intellectual disability classification. Multiple factors are involved in intellectual disability including genetic inheritance and environmental conditions.</title>
</caption>
<graphic xlink:href="f1000research-9-17823-g0001"></graphic>
</fig>
<sec>
<title>Cytogenetic abnormalities</title>
<p>The identification of genetic factors causing ID has advanced in terms of number and type with recent developments in cytogenetic techniques. The first genetic test used in the investigation of ID was karyotyping
<sup><xref ref-type="bibr" rid="ref-16">16</xref></sup> to identify aneuploidies, such as Down’s syndrome (trisomy 21) and Edwards syndrome (trisomy 18), and large structural re-arrangements such as insertions, deletions, and duplications
<sup><xref ref-type="bibr" rid="ref-17">17</xref>,
<xref ref-type="bibr" rid="ref-18">18</xref></sup>. Karyotyping detects only large deletions or insertions owing to its low resolution. Fluorescence
<italic>in situ</italic> hybridization (FISH) is used to detect structural abnormalities and numerical changes on chromosomes. Specific probes are used in FISH for the analysis of chromosomal aberration
<sup><xref ref-type="bibr" rid="ref-19">19</xref></sup>. A number of studies on ID describe the growing benefits of using NGS in clinics for diagnostic purposes
<sup><xref ref-type="bibr" rid="ref-20">20</xref></sup>.</p>
</sec>
<sec>
<title>Chromosomal aberrations</title>
<p>An extra copy of chromosome 21 as a result of an error in cell division can cause a trisomy known as Down’s syndrome
<sup><xref ref-type="bibr" rid="ref-21">21</xref></sup>. It is the most frequent form of ID. The clinical features of Down’s syndrome include dysmorphic features, seizures, psychomotor slowing, and congenital malformation. These conditions may not be present in each affected individual
<sup><xref ref-type="bibr" rid="ref-22">22</xref></sup>. Edwards syndrome is a trisomy of chromosome 18 characterized by psychomotor and cognitive brain impairment, malformation, and growth deficiency in infants
<sup><xref ref-type="bibr" rid="ref-23">23</xref></sup>. The occurrence of Edwards syndrome is 1 out of 8,000 live births. The mortality rate is very high with this condition; only 5–10% of affected children survive after the first year of life
<sup><xref ref-type="bibr" rid="ref-24">24</xref></sup>. Patau syndrome is a trisomy of chromosome 13, characterized by malformations of the central nervous system (CNS). The occurrence of this syndrome is 1 in 12,000 in the general population
<sup><xref ref-type="bibr" rid="ref-23">23</xref></sup>. The survival rate is very low in infants with trisomy 13, but it depends on the severity of the condition in infants, i.e. whether or not there are cerebral, cardiac, or other congenital malformations
<sup><xref ref-type="bibr" rid="ref-25">25</xref></sup>.</p>
</sec>
<sec>
<title>Copy number variation</title>
<p>CNVs are small segments of DNA that vary in number. Usually each individual carries two copies: one that comes from the maternal side and one from the paternal side. Variations in copy number occur through duplications and deletions of the small DNA segments. But not all copy numbers, that are either a deletion or duplication, are pathogenic to humans
<sup><xref ref-type="bibr" rid="ref-26">26</xref>,
<xref ref-type="bibr" rid="ref-27">27</xref></sup>. The largest database for CNVs (DGV) is available online (
<ext-link ext-link-type="uri" xlink:href="http://www.dgv.tcag.ca/">www.dgv.tcag.ca</ext-link>)
<sup><xref ref-type="bibr" rid="ref-28">28</xref></sup>. Decipher is another database used by clinicians to compare clinical and genetic information for the identification and interpretation of pathogenic variants (sequence variants and copy number variants) in patients with ID
<sup><xref ref-type="bibr" rid="ref-29">29</xref></sup>. CNVs causing
<italic>de novo</italic> and inherited mutations have been associated with ID. A study on a large cohort reported 118 rare
<italic>de novo</italic> CNVs
<sup><xref ref-type="bibr" rid="ref-30">30</xref></sup>. Analysis of these reported CNVs and candidate genes pinpointed 10 genes with loss of function associated with ID
<sup><xref ref-type="bibr" rid="ref-31">31</xref></sup>. CNVs cannot be visibly detected with a light microscope. Array comparative genomic hybridization (CGH) can perform rapid genome-wide analysis at a high resolution and detect CNVs, gain or loss, at the chromosomal level
<sup><xref ref-type="bibr" rid="ref-32">32</xref></sup>. Array CGH analysis of unresolved ID cases increased the identification of pathogenic CNVs up to 13% in recent years. Phenotypes associated with these 13% of cases are congenital defects, primary microcephaly, and short stature
<sup><xref ref-type="bibr" rid="ref-33">33</xref></sup>. A disorder (Online Mendelian Inheritance in Man [OMIM] #612001) with microdeletion on 15q13.3 shows an ID phenotype with a complex variety of seizures, autism, and psychiatric conditions
<sup><xref ref-type="bibr" rid="ref-34">34</xref>,
<xref ref-type="bibr" rid="ref-35">35</xref></sup>. SNP array is also a new technique as compared to array CGH which can detect CNVs
<sup><xref ref-type="bibr" rid="ref-36">36</xref></sup>. A novel genetic disorder related to ID with a 3q29 microdeletion was reported using microarray techniques
<sup><xref ref-type="bibr" rid="ref-37">37</xref></sup>.</p>
</sec>
<sec>
<title>Whole exome and genome sequencing</title>
<p>Whole exome sequencing (WES) is an efficient technology that can increase the diagnostic yield when searching for alleles causing rare Mendelian disorders. Exome analysis examines the protein’s encoding region, where an estimated 85% of disease-causing mutations are believed to occur
<sup><xref ref-type="bibr" rid="ref-38">38</xref></sup>. It has been an invaluable tool in gene discovery for ID. WES performed on three members of a family with autosomal dominant ID (MRD44; 617061) showed a heterozygous mutation, a 1 bp deletion (c.4466delA, NM_007118) in exon 30 of the
<italic>TRIO</italic> gene. This mutation resulted in a framshift and premature termination (Gln1489ArgfsTer11) in the
<italic>GEFD1</italic> domain. A 9-year-old girl with autosomal dominant ID was also found to carry a
<italic>de novo</italic> heterozygous c.3239A-T transversion (c.3239A-T, NM_007118) in exon 19 of the
<italic>TRIO</italic> gene, which causes changes in the spectrin repeat domain
<sup><xref ref-type="bibr" rid="ref-39">39</xref></sup>. Whole genome sequencing (WGS) allows examination of single-nucleotide variants (SNVs), indels, structural variants (SVs), and CNVs in both the ~1% part of the genome that encodes protein sequences and the ~99% of remaining non-coding sequences. Therefore, WGS has more reliable sequence coverage with more uniformity. It is likely to reveal many novel variants and genes and derive new scientific and clinical findings for ID. With the rapid drop in sequencing cost and the ability of WGS to rapidly produce large volumes of data, it is becoming a powerful tool for genomic research.</p>
</sec>
</sec>
<sec>
<title>Inherited mutations causing intellectual disability</title>
<p>Single gene disorders are grouped into different types on the basis of inheritance pattern
<sup><xref ref-type="bibr" rid="ref-40">40</xref></sup>.</p>
<sec>
<title>Autosomal recessive intellectual disability</title>
<p>Autosomal recessive ID is a genetically heterogeneous group of disorders
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>. Autosomal recessive ID occurs in syndromic and non-syndromic forms. The syndromic type of ID is characterized by intellectual problems occurring with a group of other phenotypic features
<sup><xref ref-type="bibr" rid="ref-42">42</xref></sup>. Non-syndromic ID is characterized by a lack of associated pathology. Genes linked with non-syndromic ID are being studied to understand the normal variation in intelligence
<sup><xref ref-type="bibr" rid="ref-43">43</xref></sup>. Distinction in intelligence quotient (IQ) is linked with those genes that can also cause large variations in intellectual ability when mutated. Homozygosity mapping is performed to check the autosomal recessive causes of ID in consanguineous families with affected siblings
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup>. OMIM and SysID (
<ext-link ext-link-type="uri" xlink:href="http://sysid.cmbi.umcn.nl/">http://sysid.cmbi.umcn.nl/</ext-link>) search results show that 399 genes can cause autosomal recessive ID (see Table 2,
<italic>Extended data</italic>).</p>
</sec>
<sec>
<title>Autosomal dominant intellectual disability</title>
<p>The inheritance pattern of autosomal dominant ID is when an individual carries one copy of a mutant allele and one normal allele on a gene. Autosomal dominant ID is caused by heterozygous mutations in different reported genes and CNVs. Tuberous sclerosis, neurofibromatosis, and myotonic dystrophy are autosomal dominant disorders linked with ID
<sup><xref ref-type="bibr" rid="ref-45">45</xref></sup>. SNP microarray analysis of the methyl binding domain gene on chromosome 2q23.1 showed that a 200 kb deletion in exon 6 of a female patient was associated with autosomal dominant ID
<sup><xref ref-type="bibr" rid="ref-46">46</xref></sup>. It is difficult to find the estimated frequency of mutations in autosomal dominant ID genes.
<italic>ARID1B</italic>,
<italic>SYNGAP1</italic>,
<italic>DYRK1A</italic>,
<italic>MED13L</italic>,
<italic>KCNQ2</italic>,
<italic>CTNNB1</italic>,
<italic>STXB1</italic>,
<italic>KMT2A</italic>,
<italic>PACS1</italic>,
<italic>FOXP1</italic>, and
<italic>SMARCA2</italic> are the most commonly mutated autosomal dominant ID genes
<sup><xref ref-type="bibr" rid="ref-47">47</xref>,
<xref ref-type="bibr" rid="ref-48">48</xref></sup>. Some of these genes are essential for neuronal differentiation in the developing brain and play important roles in synaptic formation and transmission
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>. The outcomes of our OMIM search show that in total around 180 genes or loci, as reported in the literature, are involved in autosomal dominant ID (see Table 3,
<italic>Extended data</italic>).</p>
</sec>
<sec>
<title>X-linked intellectual disability</title>
<p>The human X-chromosome comprises 5% of the human genome, but an increasing number of genetic diseases are associated with the X chromosome; approximately 10–12% of X-chromosome genes have been linked with ID
<sup><xref ref-type="bibr" rid="ref-50">50</xref></sup>. X-linked recessive fragile X syndrome occurs on chromosome Xq27.3 in the
<italic>FMR1</italic> gene at the 5ʹ untranslated region (UTR) owing to the expansion of CGG trinucleotide repeats
<sup><xref ref-type="bibr" rid="ref-51">51</xref></sup>. Fragile X syndrome is clinically characterized as ID; phenotypically, patients show dysmorphic facial features and protruded ears.
<italic>FMR1</italic> encodes for a protein that provides RNA stability and plays a key role in brain development and neuronal plasticity. Deficiency of the FMRP protein causes suppression or excitation of GABA that results in low synaptic connections, leading to syndromic features in patients
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>. The number of new X-linked ID genes identified has increased rapidly over the last few years with the use of NGS. More than 140 known X-linked genes have been reported
<sup><xref ref-type="bibr" rid="ref-53">53</xref>,
<xref ref-type="bibr" rid="ref-54">54</xref></sup>.</p>
</sec>
</sec>
<sec>
<title>Identification of candidate and novel intellectual disability genes</title>
<p>Different techniques have been used to identify novel ID-causing genes over the past few decades. For the identification of novel or candidate genes in affected families, it is necessary to reconstruct the family pedigree and perform some clinical investigation before reaching any conclusion
<sup><xref ref-type="bibr" rid="ref-55">55</xref>,
<xref ref-type="bibr" rid="ref-56">56</xref></sup>. The introduction of robust microarray technologies in research has increased the power of identification; SNP arrays can detect small deletions and micro duplications in the probands
<sup><xref ref-type="bibr" rid="ref-57">57</xref></sup>. NGS has accelerated the speed of identification of novel ID-causing genes. NGS technology has become very popular over the past 5 years, with a considerable number of new ID genes and candidate genes reported. NGS can detect SNVs and small insertions/deletions in the whole genome.</p>
</sec>
<sec>
<title>
<italic>In vitro</italic> and
<italic>in vivo</italic> study of intellectual disability</title>
<p>Biological assays can be used to study any undefined variant and its role or pathogenicity. These assays can be used in mutated cells and also directly in patient-derived cells
<sup><xref ref-type="bibr" rid="ref-58">58</xref></sup>. To identify the pathogenicity of candidate ID genes, electrophysiological studies of SH-SY5Y neuronal cell lines are a very powerful approach
<sup><xref ref-type="bibr" rid="ref-59">59</xref></sup> to capture early cortical development with high fidelity, thus helping to study genes that are relevant in early cortical development and associated with ID
<sup><xref ref-type="bibr" rid="ref-60">60</xref></sup>.
<italic>In vivo</italic> studies of candidate ID genes provide additional information regarding pathogenicity. Different animal models can be used to study ID genes. CRBN knockout (CrbnKO) mice have been used to study learning and memory tasks. Loss of CRBN results in memory problems, learning problems when AMPK activity is accelerated, blocking of mTORC1 signaling, and a decreased level of glutamatergic synaptic proteins. These findings show that the CrbnKO mouse is an ideal animal model to understand the molecular mechanisms of learning and memory problems in ID patients
<sup><xref ref-type="bibr" rid="ref-61">61</xref></sup>. Zebrafish can also be used as a model organism to study the function of genes associated with ID. Zebrafish have unique features including the rapid development of embryos and easy visualization of the nervous system during developmental stages, which make them an ideal organism to study the function of genes. Overexpression comparison can be performed between the wild-type
<italic>PK1A</italic> gene and the zebrafish ortholog of
<italic>PK1A</italic>. In this case, zebrafish mutants show severe phenotypes as compared to the wild-type, and a mutant
<italic>PK1A</italic> gene has been reported in patients with epilepsy. These results signify that the mutation changes the
<italic>in vivo</italic> function of
<italic>PK1A</italic>
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>. In addition, the
<italic>TAF1</italic> gene is associated with ID. Functional study of this gene was performed by using a zebrafish knockout model. Severe phenotypes were observed during embryogenesis and neurodevelopment in the zebrafish
<italic>TAF1</italic> knockout model
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup>. The heterogeneity of ID makes it very difficult to validate candidate genes as causative ID genes, but
<italic>in vitro</italic> and
<italic>in vivo</italic> studies provide grounds for conclusively identifying certain genes. Single-cell transcriptomics and quantitative proteomics can also be used to improve our understanding of the global changes in the central nervous system when the genome-edited organism is available.</p>
</sec>
<sec>
<title>CRISPR–Cas9 gene editing tool</title>
<p>The identification of causal genes and their functional analysis requires further understanding of disease mechanisms, especially for potential therapies, even if we do not have a full understanding of the biological functions. Acknowledging this, clustered regularly interspaced short palindromic repeats (CRISPR)–Cas9 is an RNA control nuclease system that has become essential for gene editing and correcting mutated genes. It provides potential treatment options for genetic disorders that cause ID (
<xref ref-type="fig" rid="f3">Figure 3</xref>). This system has been applied recently to mammalian genomes to stop the expression of the disease gene or to edit mutated genes, thereby correcting the mutation. CRISPR–Cas9 technology will possibly cure diseases that have no treatment option available, such as trinucleotide repeat expansion diseases causing neurological disorders
<sup><xref ref-type="bibr" rid="ref-64">64</xref></sup>. CRISPR–Cas9 systems have been used on fragile X syndrome caused by the extension of trinucleotide repeats, which results in deteriorated levels of FMR1 protein and Huntington disease (HD) models. No treatment is available for these conditions
<sup><xref ref-type="bibr" rid="ref-65">65</xref></sup>. Induced pluripotent stem cells (iPSCs) of patients with fragile X syndrome in the
<italic>FRX</italic> gene upstream of the CGH repeat were targeted with expressed CRISPR–Cas9 nuclease along with single guide RNA (sgRNA) and resulted in the reactivation of the FMR1 protein
<sup><xref ref-type="bibr" rid="ref-66">66</xref></sup>. Further studies show that two sgRNA-guided methods that flanked the trinucleotide CGG repeat produced two double-stranded breaks and the recombination of the breaks resulted in the deletion of repeats. The deletion of repeats resulted in an increased FMR1 protein level
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>. HD is caused by trinucleotide repeat extensions in the coding region of the huntingtin gene (
<italic>HTT</italic>)
<sup><xref ref-type="bibr" rid="ref-68">68</xref></sup>. The CRISPR–Cas9 system has been used recently in the treatment of HD. iPSCs derived from a HD patient were corrected by using CRISPR–Cas9 that selectively inactivated the mutant
<italic>HTT</italic> gene without altering the normal allele of the same gene
<sup><xref ref-type="bibr" rid="ref-69">69</xref>,
<xref ref-type="bibr" rid="ref-70">70</xref></sup>. HD patient fibroblast cell lines were used to show that CAG repeats can be precisely excised using CRISPR–Cas9 nickase from the
<italic>HTT</italic> gene
<sup><xref ref-type="bibr" rid="ref-71">71</xref></sup>. Strict guidelines must be adopted to avoid the exploitation of the safety and security weakness in genome editing techniques as well as to reduce the risk of off-site editing of genome and epigenetic changes with the help of further research. Adopting appropriate biosafety levels for genome editing to stop contamination is important but so is applying rules to cover the biosecurity of gene editing
<sup><xref ref-type="bibr" rid="ref-72">72</xref></sup>. Further studies are needed before the application of gene therapy to the treatment of these diseases.</p>
<fig fig-type="figure" id="f3" orientation="portrait" position="anchor">
<label>Figure 3. </label>
<caption>
<title>The CRISPR–Cas9 system used to correct extension repeats in the huntingtin gene (
<italic>HTT</italic>) by using single-guide RNA (sgRNA) on both sides of the repeats and Cas9 nuclease, creating nicks and removing the CAG repeats, blocking further extension.</title>
</caption>
<graphic xlink:href="f1000research-9-17823-g0002"></graphic>
</fig>
</sec>
<sec sec-type="conclusions">
<title>Conclusions and the future direction of intellectual disability genetics</title>
<p>The prevalence of ID varies from country to country, and it is especially low in developed countries as compared to less-developed countries
<sup><xref ref-type="bibr" rid="ref-73">73</xref>,
<xref ref-type="bibr" rid="ref-74">74</xref></sup>. The identification of genes causing ID rapidly increased over the past 3 to 5 years owing to the use of sophisticated sequencing techniques. The diagnosis of ID patients became easy with new massively parallel sequencing methods and the help of different human variant databases. The heterogeneity of ID makes it difficult for etiological diagnosis; however, WES is likely to be used as the first-line test for ID probands. NGS improves our understanding of the genetic origin of ID. Not all ID-causing genes have been identified yet, but a combined approach of sequencing techniques, functional analysis, and bioinformatics will help to identify new ID-causing genes. This approach will potentially provide a new way of treating ID. Although ID genes can be therapeutically targeted using the CRISPR–Cas-9 system, this method and its application in mammals is still emerging, and many regulatory, methodological, and off-target effects still need to be understood.</p>
<p>The genomic understanding of ID has primarily come from developed countries, and our knowledge in developing countries is very limited. This is important, as many of these countries have a young population and culturally prefer large families, indicating that the burden of ID and other childhood disorders will increase before technology is developed enough to treat these conditions. Therefore, early diagnosis, education, and genetic counseling will be important for families suffering with these conditions. In addition, many of the genes in developing countries are likely to have founder effects that may be amenable to diagnosis in cultural groups and demographic areas, accelerating diagnosis and revealing carrier status to help family planning.</p>
</sec>
<sec>
<title>Abbreviations</title>
<p>CGH, comparative genomic hybridization; CNV, copy number variation; CRISPR, clustered regularly interspaced short palindromic repeats; FISH, fluorescence
<italic>in situ</italic> hybridization; HD, Huntington's disease; ID, intellectual disability; iPSC, induced pluripotent stem cell; NGS, next-generation sequencing; OMIM, Online Mendelian Inheritance in Man; sgRNA, single guide RNA; SNV, single nucleotide variation; WES, whole exome sequencing.</p>
</sec>
<sec sec-type="data-availability">
<title>Data availability</title>
<sec>
<title>Extended data</title>
<p>Harvard Dataverse: Replication Data for: The Genetics of Intellectual Disability Review Tables,
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7910/DVN/MMUNLR">https://doi.org/10.7910/DVN/MMUNLR</ext-link>
<sup><xref ref-type="bibr" rid="ref-75">75</xref></sup>
</p>
<p>This project contains the following extended data:</p>
<list list-type="bullet">
<list-item>
<p>Table 1: Estimated total number of genes involved in Intellectual Disability Genes from Literature search and from genome England Database</p>
</list-item>
</list>
<p>Harvard Dataverse: The Genetics of Intellectual Disability,
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7910/DVN/AEKQOL">https://doi.org/10.7910/DVN/AEKQOL</ext-link>
<sup><xref ref-type="bibr" rid="ref-76">76</xref></sup>
</p>
<p>This project contains the following extended data:</p>
<list list-type="bullet">
<list-item>
<p>Table 2: List of Genes causing Autosomal Recessive Intellectual Disability</p>
</list-item>
</list>
<p>Harvard Dataverse: Replication Data for: The Genetics of Intellectual Disability,
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7910/DVN/9BJDI6">https://doi.org/10.7910/DVN/9BJDI6</ext-link>
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup>
</p>
<p>This project contains the following extended data:</p>
<list list-type="bullet">
<list-item>
<p>Table 3: List of Autosomal Dominant Genes in Omim and PubMed DataBase</p>
</list-item>
</list>
<p>Data are available under the terms of the
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons Zero "No rights reserved" data waiver</ext-link> (CC0 1.0 Public domain dedication).</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank the participants and their families for their essential help with this work. They also thank the National Institute for Health Research Biomedical Research Centre at UCLH/UCL.</p>
</ack>
<ref-list>
<ref id="ref-1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bertelli</surname><given-names>MO</given-names></name><name><surname>Munir</surname><given-names>K</given-names></name><name><surname>Harris</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>“Intellectual developmental disorders”: reflections on the international consensus document for redefining “mental retardation-intellectual disability” in ICD-11.</article-title>
<source/><italic toggle="yes">Adv Ment Health Intellect Disabil.</italic>
<year>2016</year>;<volume>10</volume>(<issue>1</issue>):<fpage>36</fpage>–<lpage>58</lpage>.
<pub-id pub-id-type="doi">10.1108/AMHID-10-2015-0050</pub-id>
<!--<pub-id pub-id-type="pmcid">4822711</pub-id>-->
<pub-id pub-id-type="pmid">27066217</pub-id></mixed-citation>
</ref>
<ref id="ref-2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harripaul</surname><given-names>R</given-names></name><name><surname>Vasli</surname><given-names>N</given-names></name><name><surname>Mikhailov</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families.</article-title>
<source/><italic toggle="yes">Mol Psychiatry.</italic>
<year>2018</year>;<volume>23</volume>(<issue>4</issue>):<fpage>973</fpage>–<lpage>984</lpage>.
<pub-id pub-id-type="doi">10.1038/mp.2017.60</pub-id>
<pub-id pub-id-type="pmid">28397838</pub-id></mixed-citation>
</ref>
<ref id="ref-3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Redin</surname><given-names>C</given-names></name><name><surname>Gérard</surname><given-names>B</given-names></name><name><surname>Lauer</surname><given-names> J</given-names></name><etal></etal></person-group>:
<article-title>Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing.</article-title>
<source/><italic toggle="yes">J Med Genet.</italic>
<year>2014</year>;<volume>51</volume>(<issue>11</issue>):<fpage>724</fpage>–<lpage>736</lpage>.
<pub-id pub-id-type="doi">10.1136/jmedgenet-2014-102554</pub-id>
<!--<pub-id pub-id-type="pmcid">4215287</pub-id>-->
<pub-id pub-id-type="pmid">25167861</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718553722">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kahrizi</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Hosseini </surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Effect of inbreeding on intellectual disability revisited by trio sequencing.</article-title>
<source/><italic toggle="yes">Clin Genet.</italic>
<year>2019</year>;<volume>95</volume>(<issue>1</issue>):<fpage>151</fpage>–<lpage>159</lpage>.
<pub-id pub-id-type="doi">10.1111/cge.13463</pub-id>
<pub-id pub-id-type="pmid">30315573</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734227994">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Kahrizi</surname><given-names>K</given-names></name><name><surname>Musante</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Genetics of intellectual disability in consanguineous families.</article-title>
<source/><italic toggle="yes">Mol Psychiatry.</italic>
<year>2019</year>;<volume>24</volume>(<issue>7</issue>):<fpage>1027</fpage>–<lpage>1039</lpage>.
<pub-id pub-id-type="doi">10.1038/s41380-017-0012-2</pub-id>
<pub-id pub-id-type="pmid">29302074</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732403372">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teng</surname><given-names>S</given-names></name></person-group>:
<article-title>NGS for Sequence Variants</article-title>. In
<italic>Translational Biomedical Informatics.</italic>Springer.
<italic>Adv Exp Med Biol.</italic>
<year>2016</year>;<volume>939</volume>:<fpage>1</fpage>–<lpage>20</lpage>.
<pub-id pub-id-type="doi">10.1007/978-981-10-1503-8_1</pub-id>
<pub-id pub-id-type="pmid">27807741</pub-id></mixed-citation>
</ref>
<ref id="ref-7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harripaul</surname><given-names>R</given-names></name><name><surname>Noor</surname><given-names>A</given-names></name><name><surname>Ayub</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>The Use of Next-Generation Sequencing for Research and Diagnostics for Intellectual Disability.</article-title>
<source/><italic toggle="yes">Cold Spring Harb Perspect Med.</italic>
<year>2017</year>;<volume>7</volume>(<issue>3</issue>): pii: a026864.
<pub-id pub-id-type="doi">10.1101/cshperspect.a026864</pub-id>
<!--<pub-id pub-id-type="pmcid">5334248</pub-id>-->
<pub-id pub-id-type="pmid">28250017</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727365838">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palmer</surname><given-names>E</given-names></name><name><surname>Speirs</surname><given-names>H</given-names></name><name><surname>Taylor</surname><given-names>PJ</given-names></name><etal></etal></person-group>:
<article-title>Changing interpretation of chromosomal microarray over time in a community cohort with intellectual disability.</article-title>
<source/><italic toggle="yes">Am J Med Genet A.</italic>
<year>2014</year>;<volume>164A</volume>(<issue>2</issue>):<fpage>377</fpage>–<lpage>385</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.a.36279</pub-id>
<pub-id pub-id-type="pmid">24311194</pub-id></mixed-citation>
</ref>
<ref id="ref-9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zablotskaya</surname><given-names>A</given-names></name><name><surname>Van Esch</surname><given-names>H</given-names></name><name><surname>Verstrepen</surname><given-names>KJ</given-names></name><etal></etal></person-group>:
<article-title>Mapping the landscape of tandem repeat variability by targeted long read single molecule sequencing in familial X-linked intellectual disability.</article-title>
<source/><italic toggle="yes">BMC Med Genomics.</italic>
<year>2018</year>;<volume>11</volume>(<issue>1</issue>):<fpage>123</fpage>.
<pub-id pub-id-type="doi">10.1186/s12920-018-0446-7</pub-id>
<!--<pub-id pub-id-type="pmcid">6299999</pub-id>-->
<pub-id pub-id-type="pmid">30567555</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734672358">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hannan</surname><given-names>AJ</given-names></name></person-group>:
<article-title>Tandem repeats mediating genetic plasticity in health and disease.</article-title>
<source/><italic toggle="yes">Nat Rev Genet.</italic>
<year>2018</year>;<volume>19</volume>(<issue>5</issue>):<fpage>286</fpage>–<lpage>298</lpage>.
<pub-id pub-id-type="doi">10.1038/nrg.2017.115</pub-id>
<pub-id pub-id-type="pmid">29398703</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732609144">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cortese</surname><given-names>A</given-names></name><name><surname>Simone</surname><given-names>R</given-names></name><name><surname>Sullivan</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Biallelic expansion of an intronic repeat in
<italic>RFC1</italic> is a common cause of late-onset ataxia.</article-title>
<source/><italic toggle="yes">Nat Genet.</italic>
<year>2019</year>;<volume>51</volume>(<issue>4</issue>):<fpage>649</fpage>–<lpage>658</lpage>.
<pub-id pub-id-type="doi">10.1038/s41588-019-0372-4</pub-id>
<!--<pub-id pub-id-type="pmcid">6709527</pub-id>-->
<pub-id pub-id-type="pmid">30926972</pub-id></mixed-citation>
</ref>
<ref id="ref-12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishiura</surname><given-names>H</given-names></name><name><surname>Doi</surname><given-names>K</given-names></name><name><surname>Mitsui</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy.</article-title>
<source/><italic toggle="yes">Nat Genet.</italic>
<year>2018</year>;<volume>50</volume>(<issue>4</issue>):<fpage>581</fpage>–<lpage>590</lpage>.
<pub-id pub-id-type="doi">10.1038/s41588-018-0067-2</pub-id>
<pub-id pub-id-type="pmid">29507423</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732796809">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Bang</surname><given-names>S</given-names></name><name><surname>Yoo</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>
<italic>De novo</italic> emergence and potential function of human-specific tandem repeats in brain-related loci.</article-title>
<source/><italic toggle="yes">Hum Genet.</italic>
<year>2019</year>;<volume>138</volume>(<issue>6</issue>):<fpage>661</fpage>–<lpage>672</lpage>.
<pub-id pub-id-type="doi">10.1007/s00439-019-02017-5</pub-id>
<pub-id pub-id-type="pmid">31069507</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735765791">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Winnepenninckx</surname><given-names>B</given-names></name><name><surname>Rooms</surname><given-names>L</given-names></name><name><surname>Kooy</surname><given-names>RF</given-names></name></person-group>:
<article-title>Mental retardation: a review of the genetic causes.</article-title>
<source/><italic toggle="yes">Br J Dev Disabil.</italic>
<year>2003</year>;<volume>49</volume>(<issue>96</issue>):<fpage>29</fpage>–<lpage>44</lpage>.
<pub-id pub-id-type="doi">10.1179/096979503799104138</pub-id>
</mixed-citation>
</ref>
<ref id="ref-15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Milani</surname><given-names>D</given-names></name><name><surname>Ronzoni</surname><given-names>L</given-names></name><name><surname>Esposito</surname><given-names>S</given-names></name></person-group>:
<article-title>Genetic Advances in Intellectual Disability.</article-title>
<source/><italic toggle="yes">J Pediatr Genet.</italic>
<year>2015</year>;<volume>4</volume>(<issue>3</issue>):<fpage>125</fpage>–<lpage>127</lpage>.
<pub-id pub-id-type="doi">10.1055/s-0035-1564438</pub-id>
<!--<pub-id pub-id-type="pmcid">4918716</pub-id>-->
<pub-id pub-id-type="pmid">27617122</pub-id></mixed-citation>
</ref>
<ref id="ref-16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tjio</surname><given-names>JH</given-names></name><name><surname>Levan</surname><given-names>A</given-names></name></person-group>:
<article-title>The chromosome number of man.</article-title>
<source/><italic toggle="yes">Hereditas.</italic>
<year>1956</year>;<volume>42</volume>(<issue>1–2</issue>):<fpage>1</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1601-5223.1956.tb03010.x</pub-id>
</mixed-citation>
</ref>
<ref id="ref-17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raymond</surname><given-names>FL</given-names></name><name><surname>Tarpey</surname><given-names>P</given-names></name></person-group>:
<article-title>The genetics of mental retardation.</article-title>
<source/><italic toggle="yes">Hum Mol Genet.</italic>
<year>2006</year>;<volume>15 Spec No 2</volume>:<fpage>R110</fpage>–<lpage>R116</lpage>.
<pub-id pub-id-type="doi">10.1093/hmg/ddl189</pub-id>
<pub-id pub-id-type="pmid">16987873</pub-id></mixed-citation>
</ref>
<ref id="ref-18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Curry</surname><given-names>CJ</given-names></name><name><surname>Stevenson</surname><given-names>RE</given-names></name><name><surname>Aughton</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics.</article-title>
<source/><italic toggle="yes">Am J Med Genet.</italic>
<year>1997</year>;<volume>72</volume>(<issue>4</issue>):<fpage>468</fpage>–<lpage>477</lpage>.
<pub-id pub-id-type="doi">10.1002/(sici)1096-8628(19971112)72:4&lt;468::aid-ajmg18&gt;3.0.co;2-p</pub-id>
<pub-id pub-id-type="pmid">9375733</pub-id></mixed-citation>
</ref>
<ref id="ref-19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fauzdar</surname><given-names>A</given-names></name><name><surname>Chowdhry</surname><given-names>M</given-names></name><name><surname>Makroo</surname><given-names>RN</given-names></name><etal></etal></person-group>:
<article-title>Rapid-prenatal diagnosis through fluorescence
<italic>in situ</italic> hybridization for preventing aneuploidy related birth defects.</article-title>
<source/><italic toggle="yes">Indian J Hum Genet.</italic>
<year>2013</year>;<volume>19</volume>(<issue>1</issue>):<fpage>32</fpage>–<lpage>42</lpage>.
<!--<pub-id pub-id-type="pmcid">3722628</pub-id>-->
<pub-id pub-id-type="pmid">23901191</pub-id></mixed-citation>
</ref>
<ref id="ref-20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Ligt</surname><given-names>J</given-names></name><name><surname>Willemsen</surname><given-names>MH</given-names></name><name><surname>van Bon</surname><given-names>BW</given-names></name><etal></etal></person-group>:
<article-title>Diagnostic exome sequencing in persons with severe intellectual disability.</article-title>
<source/><italic toggle="yes">N Engl J Med.</italic>
<year>2012</year>;<volume>367</volume>(<issue>20</issue>):<fpage>1921</fpage>–<lpage>1929</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa1206524</pub-id>
<pub-id pub-id-type="pmid">23033978</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717959021">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asim</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Muthuswamy</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>"Down syndrome: an insight of the disease".</article-title>
<source/><italic toggle="yes">J Biomed Sci.</italic>
<year>2015</year>;<volume>22</volume>(<issue>1</issue>):<fpage>41</fpage>.
<pub-id pub-id-type="doi">10.1186/s12929-015-0138-y</pub-id>
<!--<pub-id pub-id-type="pmcid">4464633</pub-id>-->
<pub-id pub-id-type="pmid">26062604</pub-id></mixed-citation>
</ref>
<ref id="ref-22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ostermaier</surname><given-names>KK</given-names></name></person-group>:
<article-title>Down syndrome: Clinical features and diagnosis</article-title>. UpToDate. Welleseley, MA: UpToDate,<year>2010</year>
<ext-link ext-link-type="uri" xlink:href="https://www.uptodate.com/contents/down-syndrome-clinical-features-and-diagnosis?search=down-syndrome-clinical-features-and%20diagnosis&amp;source=search_result&amp;selectedTitle=1~150&amp;usage_type=default&amp;display_rank=1">Reference Source</ext-link>
</mixed-citation>
</ref>
<ref id="ref-23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>DW</given-names></name><name><surname>Patau</surname><given-names>K</given-names></name><name><surname>Therman</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>A new autosomal trisomy syndrome: multiple congenital anomalies caused by an extra chromosome.</article-title>
<source/><italic toggle="yes">J Pediatr.</italic>
<year>1960</year>;<volume>57</volume>(<issue>3</issue>):<fpage>338</fpage>–<lpage>345</lpage>.
<pub-id pub-id-type="doi">10.1016/s0022-3476(60)80241-7</pub-id>
<pub-id pub-id-type="pmid">13831938</pub-id></mixed-citation>
</ref>
<ref id="ref-24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cereda</surname><given-names>A</given-names></name><name><surname>Carey</surname><given-names>JC</given-names></name></person-group>:
<article-title>The trisomy 18 syndrome.</article-title>
<source/><italic toggle="yes">Orphanet J Rare Dis.</italic>
<year>2012</year>;<volume>7</volume>(<issue>1</issue>):<fpage>81</fpage>.
<pub-id pub-id-type="doi">10.1186/1750-1172-7-81</pub-id>
<!--<pub-id pub-id-type="pmcid">3520824</pub-id>-->
<pub-id pub-id-type="pmid">23088440</pub-id></mixed-citation>
</ref>
<ref id="ref-25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plaiasu</surname><given-names>V</given-names></name><name><surname>Ochiana</surname><given-names>D</given-names></name><name><surname>Motei</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Clinical relevance of cytogenetics to pediatric practice. Postnatal findings of Patau syndrome - Review of 5 cases.</article-title>
<source/><italic toggle="yes">Maedica (Buchar).</italic>
<year>2010</year>;<volume>5</volume>(<issue>3</issue>):<fpage>178</fpage>–<lpage>85</lpage>.
<!--<pub-id pub-id-type="pmcid">3177545</pub-id>-->
<pub-id pub-id-type="pmid">21977150</pub-id></mixed-citation>
</ref>
<ref id="ref-26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sebat</surname><given-names>J</given-names></name><name><surname>Lakshmi</surname><given-names>B</given-names></name><name><surname>Troge</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Large-scale copy number polymorphism in the human genome.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2004</year>;<volume>305</volume>(<issue>5683</issue>):<fpage>525</fpage>–<lpage>528</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1098918</pub-id>
<pub-id pub-id-type="pmid">15273396</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1020207">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canales</surname><given-names>CP</given-names></name><name><surname>Walz</surname><given-names>K</given-names></name></person-group>:
<article-title>Copy number variation and susceptibility to complex traits.</article-title>
<source/><italic toggle="yes">EMBO Mol Med.</italic>
<year>2011</year>;<volume>3</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1002/emmm.201000111</pub-id>
<!--<pub-id pub-id-type="pmcid">3401997</pub-id>-->
<pub-id pub-id-type="pmid">21204264</pub-id></mixed-citation>
</ref>
<ref id="ref-28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>JR</given-names></name><name><surname>Ziman</surname><given-names>R</given-names></name><name><surname>Yuen</surname><given-names>RK</given-names></name><etal></etal></person-group>:
<article-title>The Database of Genomic Variants: a curated collection of structural variation in the human genome.</article-title>
<source/><italic toggle="yes">Nucleic Acids Res.</italic>
<year>2014</year>;<volume>42</volume>(<issue>Database issue</issue>):<fpage>D986</fpage>–<lpage>D992</lpage>.
<pub-id pub-id-type="doi">10.1093/nar/gkt958</pub-id>
<!--<pub-id pub-id-type="pmcid">3965079</pub-id>-->
<pub-id pub-id-type="pmid">24174537</pub-id></mixed-citation>
</ref>
<ref id="ref-29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bragin</surname><given-names>E</given-names></name><name><surname>Chatzimichali</surname><given-names>EA</given-names></name><name><surname>Wright</surname><given-names>CF</given-names></name><etal></etal></person-group>:
<article-title>DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation.</article-title>
<source/><italic toggle="yes">Nucleic Acids Res.</italic>
<year>2014</year>;<volume>42</volume>(<issue>Database issue</issue>):<fpage>D993</fpage>–<lpage>D1000</lpage>.
<pub-id pub-id-type="doi">10.1093/nar/gkt937</pub-id>
<!--<pub-id pub-id-type="pmcid">3965078</pub-id>-->
<pub-id pub-id-type="pmid">24150940</pub-id></mixed-citation>
</ref>
<ref id="ref-30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hehir-Kwa</surname><given-names>JY</given-names></name><name><surname>Rodríguez-Santiago</surname><given-names>B</given-names></name><name><surname>Vissers</surname><given-names>LE</given-names></name><etal></etal></person-group>:
<article-title>
<italic>De novo</italic> copy number variants associated with intellectual disability have a paternal origin and age bias.</article-title>
<source/><italic toggle="yes">J Med Genet.</italic>
<year>2011</year>;<volume>48</volume>(<issue>11</issue>):<fpage>776</fpage>–<lpage>778</lpage>.
<pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100147</pub-id>
<pub-id pub-id-type="pmid">21969336</pub-id></mixed-citation>
</ref>
<ref id="ref-31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coe</surname><given-names>BP</given-names></name><name><surname>Witherspoon</surname><given-names>K</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><etal></etal></person-group>:
<article-title>Refining analyses of copy number variation identifies specific genes associated with developmental delay.</article-title>
<source/><italic toggle="yes">Nat Genet.</italic>
<year>2014</year>;<volume>46</volume>(<issue>10</issue>):<fpage>1063</fpage>–<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1038/ng.3092</pub-id>
<!--<pub-id pub-id-type="pmcid">4177294</pub-id>-->
<pub-id pub-id-type="pmid">25217958</pub-id></mixed-citation>
</ref>
<ref id="ref-32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitra</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>J</given-names></name></person-group>:
<article-title>A genome-wide analysis of array-based comparative genomic hybridization (CGH) data to detect intra-species variations and evolutionary relationships.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2009</year>;<volume>4</volume>(<issue>11</issue>):<fpage>e7978</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0007978</pub-id>
<!--<pub-id pub-id-type="pmcid">2777320</pub-id>-->
<pub-id pub-id-type="pmid">19956659</pub-id></mixed-citation>
</ref>
<ref id="ref-33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shoukier</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>N</given-names></name><name><surname>Auber</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Array CGH in patients with developmental delay or intellectual disability: are there phenotypic clues to pathogenic copy number variants?</article-title>
<source/><italic toggle="yes">Clin Genet.</italic>
<year>2013</year>;<volume>83</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>65</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2012.01850.x</pub-id>
<pub-id pub-id-type="pmid">22283495</pub-id></mixed-citation>
</ref>
<ref id="ref-34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">, ,
<name><surname>Sharp</surname><given-names>AJ</given-names></name><name><surname>Mefford</surname><given-names>HC</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures.</article-title>
<source/><italic toggle="yes">Nat Genet.</italic>
<year>2008</year>;<volume>40</volume>(<issue>3</issue>):<fpage>322</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/ng.93</pub-id>
<!--<pub-id pub-id-type="pmcid">2365467</pub-id>-->
<pub-id pub-id-type="pmid">18278044</pub-id></mixed-citation>
</ref>
<ref id="ref-35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ben-Shachar</surname><given-names>S</given-names></name><name><surname>Lanpher</surname><given-names>B</given-names></name><name><surname>German</surname><given-names>JR</given-names></name><etal></etal></person-group>:
<article-title>Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders.</article-title>
<source/><italic toggle="yes">J Med Genet.</italic>
<year>2009</year>;<volume>46</volume>(<issue>6</issue>):<fpage>382</fpage>–<lpage>388</lpage>.
<pub-id pub-id-type="doi">10.1136/jmg.2008.064378</pub-id>
<!--<pub-id pub-id-type="pmcid">2776649</pub-id>-->
<pub-id pub-id-type="pmid">19289393</pub-id></mixed-citation>
</ref>
<ref id="ref-36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bernardini</surname><given-names>L</given-names></name><name><surname>Alesi</surname><given-names>V</given-names></name><name><surname>Loddo</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>High-resolution SNP arrays in mental retardation diagnostics: how much do we gain?</article-title>
<source/><italic toggle="yes">Eur J Hum Genet.</italic>
<year>2010</year>;<volume>18</volume>(<issue>2</issue>):<fpage>178</fpage>–<lpage>85</lpage>.
<pub-id pub-id-type="doi">10.1038/ejhg.2009.154</pub-id>
<!--<pub-id pub-id-type="pmcid">2987190</pub-id>-->
<pub-id pub-id-type="pmid">19809473</pub-id></mixed-citation>
</ref>
<ref id="ref-37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Digilio</surname><given-names>MC</given-names></name><name><surname>Bernardini</surname><given-names>L</given-names></name><name><surname>Mingarelli</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>3q29 Microdeletion: a mental retardation disorder unassociated with a recognizable phenotype in two mother-daughter pairs.</article-title>
<source/><italic toggle="yes">Am J Med Genet A.</italic>
<year>2009</year>;<volume>149</volume>(<issue>8</issue>):<fpage>1777</fpage>–<lpage>1781</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.a.32965</pub-id>
<pub-id pub-id-type="pmid">19610115</pub-id></mixed-citation>
</ref>
<ref id="ref-38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Scholl</surname><given-names>UI</given-names></name><name><surname>Ji</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>Genetic diagnosis by whole exome capture and massively parallel DNA sequencing.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2009</year>;<volume>106</volume>(<issue>45</issue>):<fpage>19096</fpage>–<lpage>19101</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0910672106</pub-id>
<!--<pub-id pub-id-type="pmcid">2768590</pub-id>-->
<pub-id pub-id-type="pmid">19861545</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1403956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pengelly</surname><given-names>RJ</given-names></name><name><surname>Greville-Heygate</surname><given-names>S</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Mutations specific to the Rac-GEF domain of
<italic>TRIO</italic> cause intellectual disability and microcephaly.</article-title>
<source/><italic toggle="yes">J Med Genet.</italic>
<year>2016</year>;<volume>53</volume>(<issue>11</issue>):<fpage>735</fpage>–<lpage>742</lpage>.
<pub-id pub-id-type="doi">10.1136/jmedgenet-2016-103942</pub-id>
<!--<pub-id pub-id-type="pmcid">5264232</pub-id>-->
<pub-id pub-id-type="pmid">27418539</pub-id></mixed-citation>
</ref>
<ref id="ref-40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Naviaux</surname><given-names>RK</given-names></name><name><surname>Nguyen</surname><given-names>KV</given-names></name></person-group>:
<article-title>POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.</article-title>
<source/><italic toggle="yes">Ann Neurol.</italic>
<year>2004</year>;<volume>55</volume>(<issue>5</issue>):<fpage>706</fpage>–<lpage>712</lpage>.
<pub-id pub-id-type="doi">10.1002/ana.20079</pub-id>
<pub-id pub-id-type="pmid">15122711</pub-id></mixed-citation>
</ref>
<ref id="ref-41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marangi</surname><given-names>G</given-names></name><name><surname>Leuzzi</surname><given-names>V</given-names></name><name><surname>Manti</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>
<italic>TRAPPC9</italic>-related autosomal recessive intellectual disability: report of a new mutation and clinical phenotype.</article-title>
<source/><italic toggle="yes">Eur J Hum Genet.</italic>
<year>2013</year>;<volume>21</volume>(<issue>2</issue>):<fpage>229</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1038/ejhg.2012.79</pub-id>
<!--<pub-id pub-id-type="pmcid">3548258</pub-id>-->
<pub-id pub-id-type="pmid">22549410</pub-id></mixed-citation>
</ref>
<ref id="ref-42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>You</surname><given-names>J</given-names></name><name><surname>Sobreira</surname><given-names>NL</given-names></name><name><surname>Gable</surname><given-names>DL</given-names></name><etal></etal></person-group>:
<article-title>A Syndromic Intellectual Disability Disorder Caused by Variants in
<italic>TELO2</italic>, a Gene Encoding a Component of the TTT Complex.</article-title>
<source/><italic toggle="yes">Am J Hum Genet.</italic>
<year>2016</year>;<volume>98</volume>(<issue>5</issue>):<fpage>909</fpage>–<lpage>918</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.03.014</pub-id>
<!--<pub-id pub-id-type="pmcid">4863664</pub-id>-->
<pub-id pub-id-type="pmid">27132593</pub-id></mixed-citation>
</ref>
<ref id="ref-43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hill</surname><given-names>WD</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Liewald</surname><given-names>DC</given-names></name><etal></etal></person-group>:
<article-title>Examining non-syndromic autosomal recessive intellectual disability (NS-ARID) genes for an enriched association with intelligence differences.</article-title>
<source/><italic toggle="yes">Intelligence.</italic>
<year>2016</year>;<volume>54</volume>:<fpage>80</fpage>–<lpage>89</lpage>.
<pub-id pub-id-type="doi">10.1016/j.intell.2015.11.005</pub-id>
<!--<pub-id pub-id-type="pmcid">4725222</pub-id>-->
<pub-id pub-id-type="pmid">26912939</pub-id></mixed-citation>
</ref>
<ref id="ref-44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basel-Vanagaite</surname><given-names>L</given-names></name><name><surname>Attia</surname><given-names>R</given-names></name><name><surname>Yahav</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>The
<italic>CC2D1A</italic>, a member of a new gene family with C2 domains, is involved in autosomal recessive non-syndromic mental retardation.</article-title>
<source/><italic toggle="yes">J Med Genet.</italic>
<year>2006</year>;<volume>43</volume>(<issue>3</issue>):<fpage>203</fpage>–<lpage>210</lpage>.
<pub-id pub-id-type="doi">10.1136/jmg.2005.035709</pub-id>
<!--<pub-id pub-id-type="pmcid">2563235</pub-id>-->
<pub-id pub-id-type="pmid">16033914</pub-id></mixed-citation>
</ref>
<ref id="ref-45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nelson</surname><given-names>DL</given-names></name></person-group>:
<article-title>Mental retardation and intellectual disability</article-title>. In
<italic>Vogel and Motulsky's Human Genetics</italic> Springer.<year>2010</year>;<fpage>663</fpage>–<lpage>680</lpage>.
<pub-id pub-id-type="doi">10.1007/978-3-540-37654-5_27</pub-id>
</mixed-citation>
</ref>
<ref id="ref-46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wagenstaller</surname><given-names>J</given-names></name><name><surname>Spranger</surname><given-names>S</given-names></name><name><surname>Lorenz-Depiereux</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation.</article-title>
<source/><italic toggle="yes">Am J Hum Genet.</italic>
<year>2007</year>;<volume>81</volume>(<issue>4</issue>):<fpage>768</fpage>–<lpage>79</lpage>.
<pub-id pub-id-type="doi">10.1086/521274</pub-id>
<!--<pub-id pub-id-type="pmcid">2227926</pub-id>-->
<pub-id pub-id-type="pmid">17847001</pub-id></mixed-citation>
</ref>
<ref id="ref-47">
<label>47</label>
<mixed-citation publication-type="journal">
<collab>Deciphering Developmental Disorders Study</collab>:
<article-title>Large-scale discovery of novel genetic causes of developmental disorders.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2015</year>;<volume>519</volume>(<issue>7542</issue>):<fpage>223</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/nature14135</pub-id>
<!--<pub-id pub-id-type="pmcid">5955210</pub-id>-->
<pub-id pub-id-type="pmid">25533962</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725287890">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wieczorek</surname><given-names>D</given-names></name></person-group>:
<article-title>Autosomal dominant intellectual disability.</article-title>
<source/><italic toggle="yes">Med Genet.</italic>
<year>2018</year>;<volume>30</volume>(<issue>3</issue>):<fpage>318</fpage>–<lpage>322</lpage>.
<pub-id pub-id-type="doi">10.1007/s11825-018-0206-2</pub-id>
<!--<pub-id pub-id-type="pmcid">6223758</pub-id>-->
<pub-id pub-id-type="pmid">30459487</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734483637">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ka</surname><given-names>M</given-names></name><name><surname>Chopra</surname><given-names>DA</given-names></name><name><surname>Dravid</surname><given-names>SM</given-names></name><etal></etal></person-group>:
<article-title>Essential Roles for ARID1B in Dendritic Arborization and Spine Morphology of Developing Pyramidal Neurons.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2016</year>;<volume>36</volume>(<issue>9</issue>):<fpage>2723</fpage>–<lpage>2742</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2321-15.2016</pub-id>
<!--<pub-id pub-id-type="pmcid">4879215</pub-id>-->
<pub-id pub-id-type="pmid">26937011</pub-id></mixed-citation>
</ref>
<ref id="ref-50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ropers</surname><given-names>HH</given-names></name><name><surname>Hamel</surname><given-names>BC</given-names></name></person-group>:
<article-title>X-linked mental retardation.</article-title>
<source/><italic toggle="yes">Nat Rev Genet.</italic>
<year>2005</year>;<volume>6</volume>(<issue>1</issue>):<fpage>46</fpage>–<lpage>57</lpage>.
<pub-id pub-id-type="doi">10.1038/nrg1501</pub-id>
<pub-id pub-id-type="pmid">15630421</pub-id></mixed-citation>
</ref>
<ref id="ref-51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bagni</surname><given-names>C</given-names></name><name><surname>Tassone</surname><given-names>F</given-names></name><name><surname>Neri</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.</article-title>
<source/><italic toggle="yes">J Clin Invest.</italic>
<year>2012</year>;<volume>122</volume>(<issue>12</issue>):<fpage>4314</fpage>–<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1172/JCI63141</pub-id>
<!--<pub-id pub-id-type="pmcid">3533539</pub-id>-->
<pub-id pub-id-type="pmid">23202739</pub-id></mixed-citation>
</ref>
<ref id="ref-52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saldarriaga</surname><given-names>W</given-names></name><name><surname>Tassone</surname><given-names>F</given-names></name><name><surname>González-Teshima</surname><given-names>LY</given-names></name><etal></etal></person-group>:
<article-title>Fragile X syndrome.</article-title>
<source/><italic toggle="yes">Colomb Med (Cali).</italic>
<year>2014</year>;<volume>45</volume>(<issue>4</issue>):<fpage>190</fpage>–<lpage>8</lpage>.
<!--<pub-id pub-id-type="pmcid">4350386</pub-id>-->
<pub-id pub-id-type="pmid">25767309</pub-id></mixed-citation>
</ref>
<ref id="ref-53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schirwani</surname><given-names>S</given-names></name><name><surname>Wakeling</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Expanding the molecular basis and phenotypic spectrum of
<italic>ZDHHC9</italic>-associated X-linked intellectual disability.</article-title>
<source/><italic toggle="yes">Am J Med Genet A.</italic>
<year>2018</year>;<volume>176</volume>(<issue>5</issue>):<fpage>1238</fpage>–<lpage>1244</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.a.38683</pub-id>
<pub-id pub-id-type="pmid">29681091</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733119650">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neri</surname><given-names>G</given-names></name><name><surname>Schwartz</surname><given-names>CE</given-names></name><name><surname>Lubs</surname><given-names>HA</given-names></name><etal></etal></person-group>:
<article-title>X-linked intellectual disability update 2017.</article-title>
<source/><italic toggle="yes">Am J Med Genet A.</italic>
<year>2018</year>;<volume>176</volume>(<issue>6</issue>):<fpage>1375</fpage>–<lpage>1388</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.a.38710</pub-id>
<!--<pub-id pub-id-type="pmcid">6049830</pub-id>-->
<pub-id pub-id-type="pmid">29696803</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733114798">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ropers</surname><given-names>HH</given-names></name></person-group>:
<article-title>Genetics of early onset cognitive impairment.</article-title>
<source/><italic toggle="yes">Annu Rev Genomics Hum Genet.</italic>
<year>2010</year>;<volume>11</volume>:<fpage>161</fpage>–<lpage>87</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev-genom-082509-141640</pub-id>
<pub-id pub-id-type="pmid">20822471</pub-id></mixed-citation>
</ref>
<ref id="ref-56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Karnebeek</surname><given-names>CD</given-names></name><name><surname>Stockler</surname><given-names>S</given-names></name></person-group>:
<article-title>Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review.</article-title>
<source/><italic toggle="yes">Mol Genet Metab.</italic>
<year>2012</year>;<volume>105</volume>(<issue>3</issue>):<fpage>368</fpage>–<lpage>381</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ymgme.2011.11.191</pub-id>
<pub-id pub-id-type="pmid">22212131</pub-id></mixed-citation>
</ref>
<ref id="ref-57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Collin</surname><given-names>RW</given-names></name><name><surname>van den Born</surname><given-names>LI</given-names></name><name><surname>Klevering</surname><given-names>BJ</given-names></name><etal></etal></person-group>:
<article-title>High-resolution homozygosity mapping is a powerful tool to detect novel mutations causative of autosomal recessive RP in the Dutch population.</article-title>
<source/><italic toggle="yes">Invest Ophthalmol Vis Sci.</italic>
<year>2011</year>;<volume>52</volume>(<issue>5</issue>):<fpage>2227</fpage>–<lpage>39</lpage>.
<pub-id pub-id-type="doi">10.1167/iovs.10-6185</pub-id>
<pub-id pub-id-type="pmid">21217109</pub-id></mixed-citation>
</ref>
<ref id="ref-58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fattahi</surname><given-names>Z</given-names></name><name><surname>Sheikh</surname><given-names>TI</given-names></name><name><surname>Musante</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Biallelic missense variants in
<italic>ZBTB11</italic> can cause intellectual disability in human.</article-title>
<source/><italic toggle="yes">Hum Mol Genet.</italic>
<year>2018</year>;<volume>27</volume>(<issue>18</issue>):<fpage>3177</fpage>–<lpage>3188</lpage>.
<pub-id pub-id-type="doi">10.1093/hmg/ddy220</pub-id>
<pub-id pub-id-type="pmid">29893856</pub-id></mixed-citation>
</ref>
<ref id="ref-59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vlachos</surname><given-names>A</given-names></name><name><surname>Korkotian</surname><given-names>E</given-names></name><name><surname>Schonfeld</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>Synaptopodin regulates plasticity of dendritic spines in hippocampal neurons.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2009</year>;<volume>29</volume>(<issue>4</issue>):<fpage>1017</fpage>–<lpage>33</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5528-08.2009</pub-id>
<!--<pub-id pub-id-type="pmcid">6665122</pub-id>-->
<pub-id pub-id-type="pmid">19176811</pub-id></mixed-citation>
</ref>
<ref id="ref-60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiocchetti</surname><given-names>A</given-names></name><name><surname>Haslinger</surname><given-names>D</given-names></name><name><surname>Stein</surname><given-names>JL</given-names></name><etal></etal></person-group>:
<article-title>Transcriptomic signatures of neuronal differentiation and their association with risk genes for autism spectrum and related neuropsychiatric disorders.</article-title>
<source/><italic toggle="yes">Transl Psychiatry.</italic>
<year>2016</year>;<volume>6</volume>(<issue>8</issue>):<fpage>e864</fpage>.
<pub-id pub-id-type="doi">10.1038/tp.2016.119</pub-id>
<!--<pub-id pub-id-type="pmcid">5022076</pub-id>-->
<pub-id pub-id-type="pmid">27483382</pub-id></mixed-citation>
</ref>
<ref id="ref-61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bavley</surname><given-names>CC</given-names></name><name><surname>Rice</surname><given-names>RC</given-names></name><name><surname>Fischer</surname><given-names>DK</given-names></name><etal></etal></person-group>:
<article-title>Rescue of Learning and Memory Deficits in the Human Nonsyndromic Intellectual Disability Cereblon Knock-Out Mouse Model by Targeting the AMP-Activated Protein Kinase-mTORC1 Translational Pathway.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2018</year>;<volume>38</volume>(<issue>11</issue>):<fpage>2780</fpage>–<lpage>2795</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0599-17.2018</pub-id>
<!--<pub-id pub-id-type="pmcid">5852658</pub-id>-->
<pub-id pub-id-type="pmid">29459374</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732715394">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bassuk</surname><given-names>AG</given-names></name><name><surname>Wallace</surname><given-names>RH</given-names></name><name><surname>Buhr</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>A homozygous mutation in human
<italic>PRICKLE1</italic> causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.</article-title>
<source/><italic toggle="yes">Am J Hum Genet.</italic>
<year>2008</year>;<volume>83</volume>(<issue>5</issue>):<fpage>572</fpage>–<lpage>581</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ajhg.2008.10.003</pub-id>
<!--<pub-id pub-id-type="pmcid">2668041</pub-id>-->
<pub-id pub-id-type="pmid">18976727</pub-id></mixed-citation>
</ref>
<ref id="ref-63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gudmundsson</surname><given-names>S</given-names></name><name><surname>Wilbe</surname><given-names>M</given-names></name><name><surname>Filipek-Górniok</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>
<italic>TAF1</italic>, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>10730</fpage>.
<pub-id pub-id-type="doi">10.1038/s41598-019-46632-8</pub-id>
<!--<pub-id pub-id-type="pmcid">6656882</pub-id>-->
<pub-id pub-id-type="pmid">31341187</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736262277">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Ran</surname><given-names>FA</given-names></name><name><surname>Cox</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Multiplex genome engineering using CRISPR/Cas systems.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2013</year>;<volume>339</volume>(<issue>6121</issue>):<fpage>819</fpage>–<lpage>23</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1231143</pub-id>
<!--<pub-id pub-id-type="pmcid">3795411</pub-id>-->
<pub-id pub-id-type="pmid">23287718</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717969062">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santoro</surname><given-names>MR</given-names></name><name><surname>Bray</surname><given-names>SM</given-names></name><name><surname>Warren</surname><given-names>ST</given-names></name></person-group>:
<article-title>Molecular mechanisms of fragile X syndrome: a twenty-year perspective.</article-title>
<source/><italic toggle="yes">Annu Rev Pathol.</italic>
<year>2012</year>;<volume>7</volume>:<fpage>219</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132457</pub-id>
<pub-id pub-id-type="pmid">22017584</pub-id></mixed-citation>
</ref>
<ref id="ref-66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>CY</given-names></name><name><surname>Halevy</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>DR</given-names></name><etal></etal></person-group>:
<article-title>Reversion of
<italic>FMR1</italic> Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2015</year>;<volume>13</volume>(<issue>2</issue>):<fpage>234</fpage>–<lpage>41</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.08.084</pub-id>
<pub-id pub-id-type="pmid">26440889</pub-id></mixed-citation>
</ref>
<ref id="ref-67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xie</surname><given-names>N</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Suhl</surname><given-names>JA</given-names></name><etal></etal></person-group>:
<article-title>Reactivation of
<italic>FMR1</italic> by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2016</year>;<volume>11</volume>(<issue>10</issue>):<fpage>e0165499</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0165499</pub-id>
<!--<pub-id pub-id-type="pmcid">5074572</pub-id>-->
<pub-id pub-id-type="pmid">27768763</pub-id></mixed-citation>
</ref>
<ref id="ref-68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bates</surname><given-names>GP</given-names></name><name><surname>Dorsey</surname><given-names>R</given-names></name><name><surname>Gusella</surname><given-names>JF</given-names></name><etal></etal></person-group>:
<article-title>Huntington disease.</article-title>
<source/><italic toggle="yes">Nat Rev Dis Primers.</italic>
<year>2015</year>;<volume>1</volume>:<fpage>15005</fpage>.
<pub-id pub-id-type="doi">10.1038/nrdp.2015.5</pub-id>
<pub-id pub-id-type="pmid">27188817</pub-id></mixed-citation>
</ref>
<ref id="ref-69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shin</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Chao</surname><given-names>MJ</given-names></name><etal></etal></person-group>:
<article-title>Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.</article-title>
<source/><italic toggle="yes">Hum Mol Genet.</italic>
<year>2016</year>;<volume>25</volume>(<issue>20</issue>):<fpage>4566</fpage>–<lpage>4576</lpage>.
<pub-id pub-id-type="doi">10.1093/hmg/ddw286</pub-id>
<!--<pub-id pub-id-type="pmcid">6078600</pub-id>-->
<pub-id pub-id-type="pmid">28172889</pub-id></mixed-citation>
</ref>
<ref id="ref-70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mattioli</surname><given-names>F</given-names></name><name><surname>Schaefer</surname><given-names>E</given-names></name><name><surname>Magee</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Mutations in Histone Acetylase Modifier
<italic>BRPF1</italic> Cause an Autosomal-Dominant Form of Intellectual Disability with Associated Ptosis.</article-title>
<source/><italic toggle="yes">Am J Hum Genet.</italic>
<year>2017</year>;<volume>100</volume>(<issue>1</issue>):<fpage>105</fpage>–<lpage>116</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.11.010</pub-id>
<!--<pub-id pub-id-type="pmcid">5223023</pub-id>-->
<pub-id pub-id-type="pmid">27939639</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727097377">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dabrowska</surname><given-names>M</given-names></name><name><surname>Juzwa</surname><given-names>W</given-names></name><name><surname>Krzyzosiak</surname><given-names>WJ</given-names></name><etal></etal></person-group>:
<article-title>Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases.</article-title>
<source/><italic toggle="yes">Front Neurosci.</italic>
<year>2018</year>;<volume>12</volume>:<fpage>75</fpage>.
<pub-id pub-id-type="doi">10.3389/fnins.2018.00075</pub-id>
<!--<pub-id pub-id-type="pmcid">5834764</pub-id>-->
<pub-id pub-id-type="pmid">29535594</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732845621">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rath</surname><given-names>J</given-names></name></person-group>:
<article-title>Safety and Security Risks of CRISPR/Cas9</article-title>. In:
<italic>Ethics Dumping</italic> Springer. Cham.<year>2018</year>;<fpage>107</fpage>–<lpage>113</lpage>.
<pub-id pub-id-type="doi">10.1007/978-3-319-64731-9_13</pub-id>
</mixed-citation>
</ref>
<ref id="ref-73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maulik</surname><given-names>PK</given-names></name><name><surname>Mascarenhas</surname><given-names>MN</given-names></name><name><surname>Mathers</surname><given-names>CD</given-names></name><etal></etal></person-group>:
<article-title>Prevalence of intellectual disability: a meta-analysis of population-based studies.</article-title>
<source/><italic toggle="yes">Res Dev Disabil.</italic>
<year>2011</year>;<volume>32</volume>(<issue>2</issue>):<fpage>419</fpage>–<lpage>436</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ridd.2010.12.018</pub-id>
<pub-id pub-id-type="pmid">21236634</pub-id></mixed-citation>
</ref>
<ref id="ref-74">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Westerinen</surname><given-names>H</given-names></name><name><surname>Kaski</surname><given-names>M</given-names></name><name><surname>Virta</surname><given-names>LJ</given-names></name><etal></etal></person-group>:
<article-title>The nationwide register-based prevalence of intellectual disability during childhood and adolescence.</article-title>
<source/><italic toggle="yes">J Intellect Disabil Res.</italic>
<year>2017</year>;<volume>61</volume>(<issue>8</issue>):<fpage>802</fpage>–<lpage>809</lpage>.
<pub-id pub-id-type="doi">10.1111/jir.12351</pub-id>
<pub-id pub-id-type="pmid">28090701</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727426079">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-75">
<label>75</label>
<mixed-citation publication-type="data">
<person-group person-group-type="author"><name><surname>Ilyas</surname><given-names>M</given-names></name></person-group>:
<article-title>Replication Data for: The Genetics of Intellectual Disability Review Tables</article-title>. Harvard Dataverse, V1.<year>2019</year>
<pub-id pub-id-type="doi">10.7910/DVN/MMUNLR</pub-id>
</mixed-citation>
</ref>
<ref id="ref-76">
<label>76</label>
<mixed-citation publication-type="data">
<person-group person-group-type="author"><name><surname>Ilyas</surname><given-names>M</given-names></name></person-group>:
<article-title>The Genetics of Intellectual Disability.</article-title>Harvard Dataverse, V1.<year>2019</year>
<pub-id pub-id-type="doi">10.7910/DVN/AEKQOL</pub-id>
</mixed-citation>
</ref>
<ref id="ref-77">
<label>77</label>
<mixed-citation publication-type="data">
<person-group person-group-type="author"><name><surname>Ilyas</surname><given-names>M</given-names></name></person-group>:
<article-title>Replication Data for: The Genetics of Intellectual Disability</article-title>. Harvard Dataverse, V1.<year>2019</year>
<pub-id pub-id-type="doi">10.7910/DVN/9BJDI6</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>